Therapeutic compositions and the treatment of lesions of connective tissue
OwnerLeon Carielinventor
Life of this patent
Estimating the term…
Abstract
A pharmaceutical composition for topical application to and treatment of lesion of connective tissue by acting on fibrillar and microfibrillar structures, proelastin, and/or on the fundamental substance and its collagen, the essential active constituent being an Alchemilla extract.
Claims6
A therapeutic method for the treatment of stretched and discolored conjunctive tissue lesions or stretch marks associated with pregnancy comprising applying topically to the affected area of a woman exhibiting such lesions a therapeutic amount of a pharmaceutical composition containing, as active ingredients in weight percent:
- Alchemilla extract -- 30-80%
- Equisetum extract -- 50-10%
- Hedera Helix extract -- 20-10%
- the total of said extracts being 100 weight percent, and continuing such treatment for a period of time until said lesions have been at least partially improved.
A therapeutic method for the treatment of lesions of conjunctive tissue comprising applying to the affected area of a person requiring such treatment a therapeutic amount of Alchemilla extract and continuing said application until the subcutaneous conjunctive tissue is substantially restored.
A therapeutic method for the treatment of stretched and discolored conjunctive tissue comprising applying to the affected area of a person requiring such treatment a therapeutic amount of Alchemilla extract and continuing said application until the sub-cutaneous conjunctive tissue is substantially restored.
A topical pharmaceutical composition for direct application to and treatment of the lesions of connective tissue including, as the pharmaceutically active ingredients in percent by weight, the following hydroglycolic extracts:
- Alchemilla extract 30-80%
- Equisetum extract 50-10%
- Hedera Helix extract 20-10%
- the total of said extracts being 100 weight percent, the extracts contained in a solution of equal parts of propylene glycol and distilled water.
Dependencies are inferred from the claim text.